The novel therapy of the medication represents a significant advance in the handling of type 2 diabetes. Distinct from existing medications, tirzepatide targets two pathways – GLP-1 and the GIP hormone – providing https://tirzepatidepeptide172334.blogdun.com/42732436/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment